Discover QuantumVision™
The Challenge
The Critical Problem in Medical Imaging
From molecule to biomarker to pathway, the loop transforms images and omics into signal, so teams see more, sooner, and decide with confidence.
Our Solution
AI-Powered Clinical Excellence
QuantumVision™ v3.0 combines dual AI engines with quantum-inspired analytics to transform medical imaging analysis through real-time streaming, multi-modal intelligence, and comprehensive 7-stage evaluation.
90% Faster
Real-time streaming analysis with progressive report generation, providing instantaneous updates throughout the diagnostic process.
500K+ Images
Dual AI engine architecture with GGF 2.0 for ultra-fast analysis and CS4 for deep differential diagnosis verification.
95%+ Accuracy
Cross-validation between two leading AI models ensuring the highest level of diagnostic accuracy and reliability.
Full Analytics
Quantum-inspired confidence scoring with multi-dimensional analysis encompassing depth, integrity, and reliability metrics.
Platform Capabilities
Technology
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
Python Ecosystem
TensorFlow/PyTorch
Advanced CNNs
HIPAA Compliant
Cloud Native
Multi-Platform
Our Difference
Quantumvision™
Image Analysis Time
Radiomic feature extraction
Several days
Minutes
Diagnostic Accuracy
Reduce interpretation errors
Frequently variable
Consistently high (>95% concordance)
Biomarker Extraction
Quantitative imaging biomarkers
Automated (500+ features)
Multi-Modality Support
MRI, CT, PET, X-ray, ultrasound
Single modality focus
All modalities
Predictive Analytics
Disease progression forecasting
Limited
Validated ML models
Clinical Integration Speed
ACS/EHR workflow deployment
Months
Hours to days
Early Disease Detection
Pre-symptomatic pattern identification
After visible progression
Detects subtle early changes
Longitudinal Tracking
Automated progression modeling
Manual comparison
Automated with change detection
Clinical Workflow Efficiency
Radiologist productivity
Mediocre at best
Significantly enhanced
Our people
Combining decades of experience in AI, medical imaging, clinical practice, and healthcare business development, our leadership drives innovation from quantum research to patient impact.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
Confidential Material
This section contains proprietary information intended for potential investors.
Market Opportunity
Born from the collective ambition of industry veterans and technology innovators, our mission is to expedite the journey of groundbreaking healthcare solutions from conception to global markets.
Confidential Material
This section contains proprietary information intended for potential investors.
The Opportunity
Investment overview
Positioned for the shift from classical to quantum-accelerated discovery.
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.